Lipid assay improves cardiovascular risk prediction: Jeff Meeusen, Ph.D.

Jeff Meeusen, Ph.D., explains how Mayo Clinic Laboratories' new MI-Heart Ceramides assay helps guide the management of patients with mildly to moderately high cholesterol. The test measures levels of lipids beyond cholesterol that boost cardiovascular risk.Show notes(00:31)Could you provide us a little bit about your background? (01:20)Could you give us a brief overview of this assay? (02:45)What patients should have this test and when should it be performed? (04:25)Could you talk a little bit about alternative test options and how they compare to our ceramides test? (05:58)Can you go a little bit further into how these results can impact patient care and how you may monitor patients in the future with this testing?